Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested β papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 1 paper. Top paper: βLong-term efficacy, safety, and patient-reported outcomes of apitegromab in patients with spinal muscular atrophy: results from the 36-month TOPAZ studyβ.
John W. Day, Darryl C. De Vivo, Jena M. Krueger, Eugenio Mercuri, A. Nascimento +10 more